Here, we investigated whether the plasma levels of Gal-9 (FL- or Tr-) or OPN (FL- or Ud-) reflected the severity of disease in COVID-19-infected individuals and the efficacy of TCZ treatment. The gene discussed is SPP1; the disease is COVID-19.